We are live on ! Find out more
TVGN icon

Tevogen Inc. Common Stock
TVGN

4 hedge funds and large institutions have $51.6M invested in Tevogen Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.3% less ownership

Funds ownership: 1.9% → 0.61% (-1.3%)

85% less capital invested

Capital invested by funds: $353M → $51.6M (-$302M)

94% less funds holding

Funds holding: 64 → 4 (-60)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 61

Holders
4
Holders Change
-60
Holders Change %
-93.75%
% of All Funds
0.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
1
Reduced
–
Closed
61
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$1.59M
2
UBS Group
UBS Group
Switzerland
+$6.37K

Top Sellers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
-$33.5M
2
Calamos Advisors
Calamos Advisors
Illinois
-$20.7M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$18.8M
4
Millennium Management
Millennium Management
New York
-$17.8M
5
WAM
Weiss Asset Management
Massachusetts
-$15.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
26
Magnetar Financial
Illinois
– -$4.4M -8,526 Closed
WRBC
27
W.R. Berkley Corp
Connecticut
– -$4.38M -8,489 Closed
SV
28
Starboard Value
New York
– -$4.34M -8,410 Closed
ACM
29
Atalaya Capital Management
New York
– -$4.13M -8,000 Closed
CCA
30
Castle Creek Arbitrage
Colorado
– -$4.13M -8,000 Closed
LP
31
LMR Partners
United Kingdom
– -$4.13M -8,000 Closed
WAM
32
Wolverine Asset Management
Illinois
– -$3.96M -7,676 Closed
HCM
33
Highbridge Capital Management
New York
– -$3.72M -7,204 Closed
KL
34
KIM LLC
Kansas
– -$3.1M -6,000 Closed
FTCM
35
First Trust Capital Management
Illinois
– -$3.1M -5,998 Closed
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
– -$2.58M -5,000 Closed
TCM
37
Tenor Capital Management
New York
– -$2.58M -5,000 Closed
Marshall Wace
38
Marshall Wace
United Kingdom
– -$2.38M -4,611 Closed
Verition Fund Management
39
Verition Fund Management
Connecticut
– -$2.07M -4,000 Closed
CCM
40
Context Capital Management
California
– -$2.06M -3,998 Closed
CSS
41
Cubist Systematic Strategies
Connecticut
– -$1.97M -3,805 Closed
WA
42
Whitebox Advisors
Minnesota
– -$1.92M -3,712 Closed
CM
43
Cohanzick Management
New York
– -$1.89M -3,657 Closed
BI
44
Bulldog Investors
New Jersey
– -$1.86M -3,598 Closed
RA
45
RiverPark Advisors
New York
– -$1.81M -3,500 Closed
PMAM
46
Picton Mahoney Asset Management
Ontario, Canada
– -$1.55M -3,000 Closed
CC
47
Centiva Capital
New York
– -$1.14M -2,215 Closed
HIM
48
HGC Investment Management
Ontario, Canada
– -$1.08M -2,100 Closed
DCM
49
Difesa Capital Management
New York
– -$1.03M -2,000 Closed
CH
50
CVI Holdings
Delaware
– -$960K -1,858 Closed
1
2
3

TVGN Hedge Fund Activity: Q1 2023 in Review

4 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q1 2023, worth a combined $51.6M — down 85% from $353M a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of TVGN and 1 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $1.59M. The largest seller was Saba Capital Management, exiting entirely with an estimated $33.5M sold.

  • 4 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q1 2023, down from 64 in Q4 2022.
  • Funds reported $51.6M of Tevogen Inc. Common Stock stock for Q1 2023, down 85% quarter-over-quarter.
  • 1 fund opened new Tevogen Inc. Common Stock positions in Q1 2023 and 61 closed out, a net change of -60 holders.
  • The largest Tevogen Inc. Common Stock buyer in Q1 2023 was Cantor Fitzgerald, an estimated $1.59M added.
  • The largest Tevogen Inc. Common Stock seller in Q1 2023 was Saba Capital Management, an estimated $33.5M sold.

Based on aggregated 13F filings for Q1 2023.